121 related articles for article (PubMed ID: 2893600)
1. Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.
Atack JR; Beal MF; May C; Kaye JA; Mazurek MF; Kay AD; Rapoport SI
Arch Neurol; 1988 Mar; 45(3):269-74. PubMed ID: 2893600
[TBL] [Abstract][Full Text] [Related]
2. Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type.
Martinez M; Frank A; Hernanz A
J Neuroimmunol; 1993; 48(2):235-40. PubMed ID: 7693756
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
Kaye JA; May C; Daly E; Atack JR; Sweeney DJ; Luxenberg JS; Kay AD; Kaufman S; Milstien S; Friedland RP
Neurology; 1988 Apr; 38(4):554-7. PubMed ID: 2451190
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
Minthon L; Edvinsson L; Gustafson L
Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
[TBL] [Abstract][Full Text] [Related]
5. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Nilsson CL; Brinkmalm A; Minthon L; Blennow K; Ekman R
Peptides; 2001 Dec; 22(12):2105-12. PubMed ID: 11786197
[TBL] [Abstract][Full Text] [Related]
6. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.
Tato RE; Frank A; Hernanz A
J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):280-3. PubMed ID: 7545739
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
8. Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis.
Vécsei L; Csala B; Widerlöv E; Ekman R; Czopf J; Pàlffy G
Brain Res Bull; 1990 Sep; 25(3):411-3. PubMed ID: 1981332
[TBL] [Abstract][Full Text] [Related]
9. Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia.
Minthon L; Edvinsson L; Gustafson L
Alzheimer Dis Assoc Disord; 1996; 10(4):197-203. PubMed ID: 8939279
[TBL] [Abstract][Full Text] [Related]
10. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin cerebrospinal fluid levels in dementia.
Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid neuropeptide Y in Alzheimer's disease.
Alom J; Galard R; Catalan R; Castellanos JM; Schwartz S; Tolosa E
Eur Neurol; 1990; 30(4):207-10. PubMed ID: 2209674
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid somatostatin in delirium.
Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
[TBL] [Abstract][Full Text] [Related]
14. Peptide histidine methionine in cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Yasuda M; Minamitani N; Maeda K
Jpn J Psychiatry Neurol; 1993 Mar; 47(1):85-90. PubMed ID: 8105129
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.
Edvinsson L; Minthon L; Ekman R; Gustafson L
Dementia; 1993; 4(3-4):167-71. PubMed ID: 8401787
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.
Martignoni E; Blandini F; Petraglia F; Pacchetti C; Bono G; Nappi G
J Neural Transm Park Dis Dement Sect; 1992; 4(3):191-205. PubMed ID: 1320891
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
Kaye JA; May C; Atack JR; Daly E; Sweeney DL; Beal MF; Kaufman S; Milstien S; Friedland RP; Rapoport SI
Ann Neurol; 1988 Nov; 24(5):647-50. PubMed ID: 2462403
[TBL] [Abstract][Full Text] [Related]
18. CSF alpha-MSH in dementia of the Alzheimer type.
Rainero I; May C; Kaye JA; Friedland RP; Rapoport SI
Neurology; 1988 Aug; 38(8):1281-4. PubMed ID: 2840605
[TBL] [Abstract][Full Text] [Related]
19. Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraine.
Vécsei L; Widerlöv E; Ekman R; Kovács K; Jelencsik I; Bozsik G; Kapócs G
Neuropeptides; 1992 Jun; 22(2):111-6. PubMed ID: 1357579
[TBL] [Abstract][Full Text] [Related]
20. Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.
Poca MA; Mataró M; Sahuquillo J; Catalán R; Ibañez J; Galard R
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):298-304. PubMed ID: 11181849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
